Laboratory Medical Billing turns documented laboratory services into payer-ready claims and follows those claims through payment. It covers more than entering a CPT or HCPCS code because laboratory payment can also depend on the test order and medical need plus CLIA status and payer policy.

A simple example shows why. A physician orders a blood test for a patient. The lab performs the test correctly. The technical work may be complete within hours. Yet the claim can still fail when the order does not show the information Medicare needs to support the test.

CMS states that the entity submitting a diagnostic laboratory claim must keep documentation of the order. It must also keep information that supports correct order processing and claim submission. The lab may also need diagnostic information supplied by the ordering practitioner.

That makes the ordering provider part of the revenue cycle. If the treating provider does not document the reason for a test then the billing team cannot safely invent that reason because medical necessity comes from the clinical record.

Documentation errors have a measurable financial effect. CMS reported a 27.2% improper payment rate for its 2024 category of other non-Medicare-fee-schedule lab tests. The projected improper payment amount was $1.3 billion. CMS said insufficient documentation accounted for 87.7% of improper payments in that category. This category includes several pathology and laboratory services. It is not a denial rate for every laboratory claim. Review the CMS laboratory compliance data.

The same pattern appears in more common tests. CMS reported a 12.1% improper payment rate for blood count lab tests in the 2024 reporting period. That represented a projected $26.4 million in improper payments.

For lab administrators this data points to one clear step: review documentation before the claim leaves the billing system. Finding a missing order today usually gives the team more options than discovering it after the payer asks for records.

The Laboratory Information System or LIS also matters. The LIS may carry order and test data into the billing workflow. MedicureMD says its laboratory billing service supports LIS and EHR access along with charge capture and claims work for molecular and clinical tests.

Labs can review MedicureMD’s laboratory billing services to see how coding and claims work can connect with existing lab systems.

Lab Claims Management tracks each laboratory claim from creation through payer response and final resolution. It stops a submitted claim from becoming an ignored claim when a payer rejects it or asks for more information.

Submission is only one event in the claim lifecycle. A claim can pass internal edits and still stop at the clearinghouse. It can reach the payer and remain pending. It can also receive a denial because the payer questions coverage or documentation.

A lab needs different actions for each outcome:

Rejected claim: Review invalid or missing claim data and correct the submission.
Pending claim: Check payer status and identify whether more information is required.
Denied claim: Review the denial reason and the record before correcting or appealing.
Paid claim: Post the payment and compare the result with the expected account balance.
These 4 paths should not sit in one general work queue. A claim that needs one missing field should not wait behind a complex appeal that may require several records.

CMS also uses National Correct Coding Initiative Medically Unlikely Edits to reduce improper Part B payments. An MUE sets a maximum number of units that would be reported for most correctly reported claims for a code and patient on the same date. CMS updates published MUE files every quarter.

This matters for high-volume laboratories. A repeated unit error can affect many claims in one billing cycle. Staff should correct the source problem instead of changing 40 claims one at a time after payer responses arrive.

CMS had already posted new MUE changes on September 1, 2026 for an October 1 effective date. That recent update shows why a lab billing team should not treat last year’s edit file as a permanent rulebook.

Claim tracking also needs ordering provider data. CMS instructs Medicare billers to report the ordering practitioner’s NPI when required for diagnostic laboratory services. The NPI is a 10-digit healthcare identifier used in HIPAA standard transactions.

A lab that receives 2,000 orders each week can turn one bad intake rule into hundreds of claim problems. The better approach is to measure recurring failures by payer and test type. Then fix the intake rule before the next batch enters billing.

MedicureMD’s medical claims management services can also support the wider claim workflow when a laboratory needs stronger tracking beyond initial submission.

Laboratory Reimbursement Services track how covered laboratory tests move from billed charges to payer-approved payment. They also help the lab spot unpaid claims and payment differences that need review.

For Medicare the Clinical Laboratory Fee Schedule plays a major role. CMS states that it pays most clinical diagnostic laboratory tests under the CLFS. Many rates are based on the weighted median of private payer rates.

The 2026 rules are especially important for lab finance teams. Congress changed the CLFS reporting timeline through the Consolidated Appropriations Act of 2026. CMS says the latest reporting period ran from May 1 through July 31, 2026 and used data collected from January 1 through June 30, 2025.

CMS also states that there is no phase-in payment reduction for 2026 under this part of CLFS implementation. Beginning in 2027 through 2029 the payment amount for an affected test may not fall by more than 15% from the amount set for the prior year.

That 15% cap does not mean every lab test will fall by 15%. It sets a limit on reductions under the referenced phase-in rules. A lab should still check the actual current fee schedule for the specific HCPCS code before estimating Medicare revenue.

CMS also changes CLFS files during the year. Its Q1 2026 file contained 2,162 records while its July Q3 file contained 2,206 records. CMS notes that including a code or payment amount in the fee schedule does not by itself mean Medicare covers that test.

That point matters. Payment rate and coverage are different entities. A fee schedule can show how Medicare would pay a covered test. Coverage rules decide whether Medicare will pay the test in the patient’s actual case.

Labs should therefore check medical necessity and payer coverage before relying on a fee schedule amount. Medicare National Coverage Determinations and Medicare Administrative Contractor policies can affect covered laboratory services. CMS provides its Medicare Coverage Database for both national and local coverage documents.

A reimbursement team should also compare expected payment with the remittance after adjudication. If 100 similar tests are each paid $8 below the expected allowed amount then the difference becomes $800. A recurring payment variance can deserve more attention than one large claim that was already worked.

This is where revenue cycle reporting becomes useful. Reports should separate payment rate problems from denials and missing claims. Those issues need different fixes.

Lab Billing Solutions should connect the order and test data with claim edits and payment tracking plus denial work and A/R follow-up. A lab should judge the solution by the full financial workflow rather than the number of software screens it offers.

Start with the lab’s current problem. One laboratory may have 4 days of charge lag. Another may submit claims quickly but carry a large balance over 90 days. A third may see frequent documentation denials for genetic tests.

A useful lab billing setup should give the organization 4 clear controls:

Order control: Staff can find missing payer or ordering provider details before claim submission.
Claim control: Rejections and denials move into clear work queues with an assigned next step.
Payment control: Staff can review ERA or EOB activity and identify unpaid or unexpected results.
A/R control: Aging reports separate new balances from 60-day and 90-day accounts that need action.
The technology should also fit the lab’s existing LIS or EHR workflow. Requiring staff to type the same order information into 3 systems creates more places for errors.

MedicureMD states that its laboratory billing workflow includes charge capture for molecular and clinical tests. It also includes pre-authorization support for certain high-cost testing and LIS or EHR access during onboarding.

MedicureMD also reports support for more than 500 physicians and 40 specialties. Its laboratory page reports an up to 98% first-pass clean claim rate. These figures come from MedicureMD and should be treated as company-reported performance information rather than a universal result for every laboratory.

Laboratories should still test a billing partner against their own accounts. Give the team examples of the lab’s most common tests and its oldest A/R. Ask how it would handle one rejected claim and one documentation denial. Then ask what report will show the status 7 days later.

For Pakistan-based healthcare administrators who support US laboratory billing the same rule applies. Remote location does not change US payer requirements. The team still needs access to current CMS rules and the lab’s payer policies plus secure clinical and billing information where authorized. CMS regulates laboratory testing through CLIA and states that the program covers about 320,000 laboratory entities.

CMS also moved CLIA certificates and fee coupons to a paperless system in 2026. It no longer mails paper versions and requires online payment of CLIA certification and survey fees.

A billing process should therefore review current digital records instead of relying on an old paper copy stored in an office file.

Laboratory AR Management follows unpaid laboratory balances after claims enter the revenue cycle. Its job is to identify why money remains open and move each recoverable account toward payment or the correct final outcome.

A/R stands for accounts receivable. An account enters A/R when the laboratory has billed a service but still has an outstanding balance. The age of that balance helps staff decide which account needs attention first.

For example, consider a lab with $400,000 in open insurance A/R. A $100,000 total sounds large but tells the administrator almost nothing by itself. The better question is how much sits at 0 to 30 days and 31 to 60 days plus 61 to 90 days and over 90 days.

Older A/R often requires a different action from new A/R. A 12-day claim may still be inside normal payer processing. A 105-day claim may need immediate review of claim history and payer deadlines.

The team should also separate A/R by cause. A denied genetic test needs a different action from a claim that the payer never received. A payment posting error needs another workflow.

CMS data shows why documentation belongs in that review. For bacterial urine culture testing the agency reported a 16.2% improper payment rate in its 2024 data with a projected improper payment amount of $9 million. CMS said insufficient documentation accounted for 100% of improper payments identified in that category during that reporting period.

This does not mean 16.2% of every urine culture claim is denied. It does show how documentation can affect payment accuracy in a specific Medicare service category.

The same lesson applies to old A/R. Billing staff should not automatically resubmit a claim because it remains unpaid. They should find the cause first.

If the payer never received the claim then the next action may be submission. If the payer denied the claim for medical necessity then sending the same claim again without new support may repeat the same result.

A/R management should also look for patterns. Suppose 25 claims from one referring office lack needed ordering information. Fixing those 25 accounts may recover current revenue. Fixing the intake process can stop the next 25 accounts from entering the same queue.

MedicureMD’s laboratory service includes billing and claim-related work for laboratories. Its broader billing operation also includes denial management and A/R follow-up plus payment posting and reporting.

That connection matters because Laboratory Revenue Cycle Management is broader than collections alone. The best A/R recovery process also tells the lab which earlier workflow created the unpaid balance.

A laboratory that wants support across claims can review MedicureMD’s medical claims management services. Labs seeking specialty support can also review Laboratory Medical Billing services for test-specific billing workflows.

Laboratory Revenue Cycle Management is the financial workflow from test order through final payment. It can cover patient and insurance data plus coding and claim submission. It also covers denial work and payment posting plus A/R. The goal is to find where a laboratory claim stops and assign the right action before the balance becomes old.

Laboratory billing focuses on creating and following claims while laboratory RCM covers the wider financial cycle. RCM can begin with order and insurance readiness before the test. It continues through claims and payment. It also reviews denials and A/R plus financial reports so the lab can fix repeat revenue problems instead of only correcting individual claims.

Medical necessity matters because Medicare requires diagnostic tests to be reasonable and necessary for the patient’s care. CMS says the treating practitioner must order the test and the record should support why the test was needed. Missing order or clinical information can create payment problems when a laboratory claim enters medical review.

The Clinical Laboratory Fee Schedule is the Medicare payment schedule for most clinical diagnostic laboratory tests. CMS states that many CLFS payments are based on the weighted median of private payer rates reported under federal law. Labs still need to check coverage because the presence of a code and fee does not itself mean Medicare covers the test.

Laboratory AR Management improves collection work by giving every unpaid balance a reason and next action. Staff can separate new claims from older balances. They can also group accounts by payer or denial cause. A 20-day pending claim should not receive the same work as a 100-day denied claim that is close to a payer deadline.

Laboratories performing testing generally need the proper CLIA certification for their test type when billing Medicare. CMS states that laboratories must be properly certified to receive Medicare or Medicaid payments. Certification rules depend on test complexity and the laboratory’s activities. CMS says CLIA currently covers about 320,000 laboratory entities.

A lab should consider outsourcing when internal staff cannot keep claims and denials or A/R current. Review at least 60 to 90 days of data first. Look at charge lag and rejected claims. Then measure denied claims and old A/R. This shows whether the lab needs billing capacity or a fix to an earlier workflow.

Your laboratory should begin with a 90-day revenue review and find the 3 reasons that create the most unpaid balances. Start with claim rejections. Then review denials and accounts over 90 days.

Do not mix every unpaid account into one number. Separate problems by test type and payer. A laboratory may discover that routine chemistry claims move well while molecular claims create most of the documentation work.

Next compare the claim with the source information. Check whether the test had a valid order. Check whether the clinical record supports the service. Review current payer coverage before changing a code simply to make the claim pay. CMS specifically requires documentation of medical necessity when diagnostic laboratory tests are ordered.

Labs should also prepare for payment changes before 2027. CMS says there was no CLFS phase-in reduction in 2026. Beginning in 2027 the annual reduction cap under the current phase-in rules becomes 15% through 2029. That makes payer and test-level reimbursement reporting more useful for future planning.

Current coding files also need active review. CMS has already issued an October 2026 CLFS and CLIA update with an implementation date of October 5, 2026. A lab that reviews those changes before implementation has more time to update billing rules than one that waits for rejected claims in October.

MedicureMD’s laboratory billing services connect test billing with claim submission and payer-focused workflows. MedicureMD also supports LIS and EHR access during laboratory billing onboarding.

The next step should be practical. Pull your oldest unpaid lab claims this week. Find the reason behind each balance. Then fix the workflow that created the largest repeat problem. That approach turns Laboratory Revenue Cycle Management from simple claim submission into a system for protecting future revenue as payer rules and laboratory payment policies continue to change.